- Lobbying
- Lobbying by Alliance for Safe Online Pharmacies (ASOP)
Lobbying Relationship
Bills mentioned
S.2002: Motor Systems Market Awareness Act of 2014
Sponsor: Mark Pryor (D-Ark.)
H.R.4095: Veterans' Compensation Cost-of-Living Adjustment Act of 2014
Sponsor: Jon Runyan (R-N.J.)
S.2002: Online Pharmacy Safety Act
Sponsor: Dianne Feinstein (D-Calif.)
H.R.4095: Online Pharmacy Safety Act
Sponsor: Bill Cassidy (R-La.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Mary Bono | Member of Congress, California 1998-2012 |
John (Kevin) Brennan | Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) Chief of Staff, Rep. Rosa DeLauro (D-CT); Legislative Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
VINCENT VENTIMIGLIA | ASSIST. SECRETARY FOR LEGISLATION, HHS ASSIST. SECRETARY OF LEGISLATION, HHS |
Sarah-Lloyd Stevenson | Legislative Assistant, Sen. Roger Wicker (R-MS); Policy Advisor, HHS Office of the Secretary; Policy Adivsor, Executive Office of the President (No lobbying of Executive Branch officials) |
Elizabeth Baney | n/a |
Kelly Nickel | n/a |
Philip Bonforte | n/a |
Beena Patel | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Management & Budget (OMB)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
U.S. Senate
Executive Office of the President (EOP)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate